With decades of experience, Sofinnova Partners' Chairman and Managing Partner Antoine Papiernik shares his thoughts on investing in life sciences and Europe

blonca9
Sep 5, 2024
1 min read

He describes Sofinnova Partners and its numerous investment strategies, the hidden gems of research expertise that can be found throughout Europe, portfolio companies, recent exits, and more.

Recent Posts

See All

As federal funding for cancer research has been jeopardized at NIH and academia, Parker Institute for Cancer Immunotherapy is one private institution ready to step up and broaden its impact

Mount Sinai has embraced AI as a drug discovery tool by launching this month its new AI Small Molecule Drug Discovery Center - Professor Avner Schlessinger tells us why

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Soumit Roy and Justin Walsh share their take on biotech and comment on companies they cover

With decades of experience, Sofinnova Partners' Chairman and Managing Partner Antoine Papiernik shares his thoughts on investing in life sciences and Europe

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight